PDA Journal of GMP and Validation in Japan
Online ISSN : 1881-1728
Print ISSN : 1344-4891
ISSN-L : 1344-4891
Special Section “FDA 21 CFR Part11 & European GMP Annex 11-Electronic Records and Electronic Signatures”
Proposal for Part11 Implementation in Pharmaceutical Industries
Shizuo IKEDA
Author information
JOURNAL FREE ACCESS

2002 Volume 4 Issue 1 Pages 37-39

Details
Abstract
  It is recommended that organization shall have a reasonable timetable for promptly modifying any systems not in compliance (including legacy systems) to make them Part11 compliant, and shall be able to demonstrate progress in implementing their timetable. The reasons: 1. It takes not so much time to recognize Part11 requiring implementation of secure, computer-generated and time-stamped audit trails etc. as global standard. 2. The Japanese pharmaceutical companies are faces to important phase to decide the implementation of Part11 in their process of globalization. 3. It may take more time to modify the existing systems such as for R&D of new medicine, manufacturing and quality control management of products.
Content from these authors
© 2002 Parenteral Drug Association Japan Chapter
Previous article Next article
feedback
Top